INVESTOR PROFILE

Asabys Partners

Asabys Partners

Asabys Partners

Spain

Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.

Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading
LOG IN
RECOMMENDED
Trustbridge Partners

Investor

Trustbridge Partners

China

Dueto

Investor

Dueto

Portugal

HaiQuan Fund

Investor

HaiQuan Fund

China

RECOMMENDED

Trustbridge Partners

Investors

Trustbridge Partners

China

Dueto

Investors

Dueto

Portugal

HaiQuan Fund

Investors

HaiQuan Fund

China

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.